Effect of Ready to Use Therapeutic Food (RUTF) Supplement After an Episode of Malaria Falciparum on Weight
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The primary objective of this study is to determine to what extent provision with RUTF will promote catch up growth in children following an acute uncomplicated episode of P. falciparum malaria.
| Condition | Intervention |
|---|---|
|
Weight Loss Weight Gain Convalescence Malaria |
Dietary Supplement: RUTF (Plumpynut®) |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | The Effectiveness of Ready to Use Therapeutic Food (RUTF) in Catch up Growth in Children After an Episode of P. Falciparum Malaria |
- weight gain [ Time Frame: 14 days ] [ Designated as safety issue: No ]
- weight gain [ Time Frame: 28 days ] [ Designated as safety issue: No ]
| Enrollment: | 180 |
| Study Start Date: | January 2009 |
| Study Completion Date: | March 2009 |
| Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: RUTF
RUTF supplement (Plumpynut®) of 500 kcal/day for 2 weeks
|
Dietary Supplement: RUTF (Plumpynut®)
Intervention group receives 500 kcal/day of RUTF for 2 weeks Control group receives no food supplement
Other Names:
|
|
No Intervention: control
no supplement given
|
Detailed Description:
Anorexia due to infection might lead to weight loss. In many settings total recovery is problematic what might result in a permanent lower weight. A short period high quality food supplementation could improve weight gain after an infection.
Children aged 6-59 months presenting with malaria caused by P. falciparum who are provided with a RUTF supplement (Plumpynut®) of 500 kcal/day for 2 weeks will show significantly better catch up growth compared to a similar patient group not provided with RUTF (at 2 weeks and 4 weeks post-intervention).
Eligibility| Ages Eligible for Study: | 6 Months to 59 Months |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age 6 to 59 months, and
- Positive rapid diagnostic test (Paracheck®) and
- Thick smear showing infection with P. falciparum and
- Informed consent from parents or guardian aged at least 18 years.
Exclusion Criteria:
- Children who are exclusively breast fed or
- Children who are severely malnourished (MUAC <110 mm and/or bilateral oedema, or WHO weight-for-Height criteria <3 Z-scores) or
- Presence of general danger signs or signs of severe malaria as defined by the WHO criteria, or
- Known history of allergy to malaria drugs, or
- Having a sibling enrolled in the study.
Contacts and Locations
More Information
Additional Information:
No publications provided by Medecins Sans Frontieres
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Ir. S. van der Kam, Médecins Sans Frontières OCA |
| ClinicalTrials.gov Identifier: | NCT00819858 History of Changes |
| Other Study ID Numbers: | MSF-nutcon01 |
| Study First Received: | January 8, 2009 |
| Last Updated: | November 13, 2009 |
| Health Authority: | Barbados: Ministry of Health |
Keywords provided by Medecins Sans Frontieres:
|
weight loss weight gain malnutrition convalescence malaria |
RUTF RUF supplementation nutrition |
Additional relevant MeSH terms:
|
Convalescence Malaria Weight Gain Weight Loss Disease Attributes Pathologic Processes |
Protozoan Infections Parasitic Diseases Body Weight Changes Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on June 17, 2013